MD Anderson and Summit Medical Group launch partnership in New Jersey

MD ANDERSON CANCER CENTER and Summit Medical Group in New Jersey announced the launch of their partnership to create the Summit Medical Group MD Anderson Cancer Center.

An extension of MD Anderson Cancer Center at Cooper in Camden, N.J., Summit Medical Group will now be clinically and operationally integrated with MD Anderson Cancer Center in Houston.

MD Anderson Cancer Center at Cooper joined MD Anderson Cancer Network, a program of MD Anderson Cancer Center, in 2013.

With a special emphasis on continuity of care, the new center will provide integrated, multidisciplinary cancer care for patients in northern New Jersey. The program, which provides medical oncology, infusion and diagnostic imaging, is already in place at Summit Medical Group’s campus in Berkeley Heights.

Plans are underway to build a state-of-the-art, 130,000-square-foot building adjacent to Summit Medical Group’s new facility in Florham Park, with future services to include radiation oncology. Groundbreaking is expected at the new site this summer.

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

White House

Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.

January 31, 2025

Vol.51 No.04

By Paul Goldberg

Capitol Hill

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services.

January 31, 2025

Vol.51 No.04

By Claire Marie Porter

Guest Editorial

Our challenge: To find zen in chaos

This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.

January 31, 2025

Vol.51 No.04

By W. Kimryn Rathmell

Guest Editorial

Foundations acquire a critical new role as federal funding for cancer research falters

The fight against cancer is complex. It’s global. And it’s indisputably expensive.

January 31, 2025

Vol.51 No.04

By Ryan Schoenfeld and Raymond N. DuBois

Guest Editorial

Cancer research fuels life-saving work

Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies.

January 31, 2025

Vol.51 No.04

By Ze’ev Ronai

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to a modeling study led by researchers at NCI.

January 31, 2025

Vol.51 No.04

By Yiqing Wang and Jacquelyn Cobb